Information Provided By:
Fly News Breaks for November 28, 2018
GEN
Nov 28, 2018 | 21:18 EDT
As noted earlier, Stifel analyst Chad Vanacore upgraded Genesis Healthcare to Buy and raised his price target to $2.50 from $2.00. The analyst cites the "stabilization of skilled nursing fundamentals, improving reimbursement outlook, and synergies from restructuring". Vanacore also points to the "potential margin improvements under new payment model and operating and financial leverage" of Genesis Healthcare.
News For GEN From the Last 2 Days
There are no results for your query GEN